Longer telomeres sound great — until you learn what else they grow

Every time a cell divides, the protective caps on the ends of its chromosomes — called telomeres — get a little shorter. Think of them as the plastic tips on a shoelace: once they wear down past a critical point, the cell can no longer divide safely and enters a dormant, aged state. Because short telomeres show up in older tissue, they became famous as a kind of 'aging clock,' and a whole industry now sells supplements promising to lengthen them.

Here's the twist the marketing skips: telomere shortening is also a cancer defense. That built-in limit on how many times a cell can divide is a brake on runaway growth. Large genetic studies (using an approach called Mendelian randomization, which uses inherited gene variants to mimic a lifelong experiment) find that people genetically predisposed to longer telomeres tend to have a higher risk of several cancers, especially melanoma and some brain and lung tumors. Longer caps let cells — including damaged ones — keep multiplying.

So telomere length isn't a simple 'longer = younger = better' dial. It's a trade-off: too short accelerates cellular aging and tissue breakdown, too long removes a safeguard against tumors. This is why chasing artificially longer telomeres is not the clean win it's often sold as, and why researchers treat telomere-lengthening pills with real caution.